XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses:    
Research and development $ 5,111 $ 7,174
General and administrative 4,534 4,107
Total operating expenses 9,645 11,281
Loss from operations (9,645) (11,281)
Non-operating income:    
Change in fair value of warrant liability 0 2
Interest income 79 182
Total non-operating income 79 184
Net loss $ (9,566) $ (11,097)
Per share information:    
Net loss per common share, basic (in dollars per share) $ (0.21) $ (0.47)
Net loss per common share, diluted (in dollars per share) $ (0.21) $ (0.47)
Weighted-average common shares outstanding, basic (in shares) 44,812,996 23,547,562
Weighted-average common shares outstanding, diluted (in shares) 44,812,996 23,547,562